IHS Chemical Week

New EPA ORD program to evaluate low-dose effects of endocrine disruptors

2:06 PM MST | December 18, 2012 | Kara Sissell

EPA says it is working on a “state of the science” paper to update its research on low-dose health effects for endocrine disruptors. The findings will provide information to help inform how EPA assesses the safety of chemicals by determining if the current methods used adequately portray possible certain links between levels of exposure and adverse health effects, the agency says. Risk assessments for low-dose effects—or nonmonotonic dose response curves (NMDRC)—for endocrine disruptors have generated considerable differences of opinion...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.


Forgot your user ID or password?
Click here to have it sent to you. 

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa